Use of catheter with 2-methacryloyloxyethyl phosphorylcholine polymer coating is associated with long-term availability of central venous port
Open Access
- 8 March 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Scientific Reports
- Vol. 11 (1), 1-6
- https://doi.org/10.1038/s41598-021-84885-4
Abstract
Central venous port (CVP) is a widely used totally implantable venous access device. Recognition of risks associated with CVP-related complications is clinically important for safe, reliable, and long-term intravenous access. We therefore investigated factors associated with CVP infection and evulsion, including the device type. A total of 308 consecutive patients with initial CVP implantation between January 2011 and December 2017 were retrospectively reviewed, and the association of clinical features with CVP-related complications were analyzed. Intraoperative and postoperative complications occurred in 11 (3.6%) and 39 (12.7%) patients, respectively. The overall rate of CVP availability at six months was 91.4%. Malignancy and 2-Methacryloyloxyethyl phosphorylcholine (MPC) polymer-coated catheter use were negatively associated with the incidence of CVP infections. Accordingly, malignancy and MPC polymer-coated catheter use were independent predictors for lower CVP evulsion rate (odds ratio, 0.23 and 0.18, respectively). Furthermore, both factors were significantly associated with longer CVP availability (hazard ratio, 0.24 and 0.27, respectively). This retrospective study identified factors associated with CVP-related complications and long-term CVP availability. Notably, MPC polymer-coated catheter use was significantly associated with a lower rate of CVP infection and longer CVP availability, suggesting the preventive effect of MPC coating on CVP infection.This publication has 14 references indexed in Scilit:
- Complications of central venous port systems: a pictorial reviewInsights into Imaging, 2019
- Perioperative antibiotics should be used for placement of implanted central venous ports: A propensity analysis evaluating riskThe American Journal of Surgery, 2018
- Clinical Predictors of Port Infections in Adult Patients with Hematologic MalignanciesJournal of Vascular and Interventional Radiology, 2018
- Predictive factors of catheter-related bloodstream infection in patients receiving home parenteral nutritionNutrition, 2018
- Complications after implantation of subcutaneous central venous ports (PowerPort®)Annals of Medicine & Surgery, 2017
- Risk factors for infectious and noninfectious complications of totally implantable venous catheters in cancer patientsJournal of Vascular Surgery. Venous and Lymphatic Disorders, 2016
- Incidence and risk factors for central venous access port-related infection in Chinese cancer patientsJournal of the Formosan Medical Association, 2015
- A retrospective analysis on the utility and complications of upper arm ports in 433 cases at a single instituteInternational Journal of Clinical Oncology, 2015
- A Case-Control Study to Identify Risk Factors for Totally Implantable Central Venous Port-Related Bloodstream InfectionCancer Research and Treatment, 2014
- Predictors of bloodstream infection associated with permanently implantable venous port in solid cancer patientsAnnals of Oncology, 2013